Transformational mergers and acquisitions activity is off the cards for GlaxoSmithKline PLC’s Consumer Healthcare business as its priorities lie elsewhere, according to the UK pharma giant's chief executive officer Emma Walmsley.
No More ‘Major’ Deals For GSK Consumer Before IPO – CEO Walmsley
GSK's CEO Emma Walmsley has effectively ruled out further big deals at its Consumer Healthcare unit before the business is separated from its parent through an IPO.
